Hetero
Gaurav Patil is a Research Associate at Hetero since May 2022, specializing in pre-formulation studies, experimental design, and the development of solid oral formulations for the regulated US market. Gaurav has experience troubleshooting existing products and managing stability, scale-up, and exhibit batches, in addition to preparing essential documentation such as Scale-up Formula Cards and Stability Protocols. Prior to this role, Gaurav served as a Production Officer at Serum Institute of India Pvt. Ltd. from July 2019 to July 2020, where responsibilities included developing experimental plans, supervising equipment maintenance, and preparing documents like User Requirement Specifications and Technical Recommendations. Gaurav holds a Master of Pharmacy in Quality Assurance and an MBA in Marketing from Savitribai Phule Pune University and SYSTEL Institute of Management & Research, respectively, as well as a Bachelor's Degree in Pharmacy.
This person is not in any offices
Hetero
4 followers
Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs. Backed by 25 years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, generics, biosimilars, custom pharmaceutical services and branded generics. The company is globally recognized for its strengths in Research and Development, manufacturing and commercialization of a wide range of products. Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide, approved by stringent global regulatory authorities. Our portfolio includes 300 plus products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology and Immunology etc. Hetero has a strong global presence in over 145+ countries and focusses on making affordable medicines accessible to patients worldwide.